-
1
-
-
0023882597
-
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs
-
Chou MJ, Lee TH, Hatzakis A, Mandalaki T, McLane MF, and Essex M: Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis 1988;157: 805-811.
-
(1988)
J Infect Dis
, vol.157
, pp. 805-811
-
-
Chou, M.J.1
Lee, T.H.2
Hatzakis, A.3
Mandalaki, T.4
McLane, M.F.5
Essex, M.6
-
2
-
-
0024794173
-
HIV-1 inactivation by antibodies: Predominance of a group-specific epitope that persists despite genetic variation
-
Berkower I, Smith GE, Giri C, and Murphy D: HIV-1 inactivation by antibodies: Predominance of a group-specific epitope that persists despite genetic variation. J Exp Med 1989;170:1681-1695.
-
(1989)
J Exp Med
, vol.170
, pp. 1681-1695
-
-
Berkower, I.1
Smith, G.E.2
Giri, C.3
Murphy, D.4
-
3
-
-
0025764679
-
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection
-
Redfield RR, Birx DL, Ketter N, Tramont E, Polonis V, et al.: A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. N Engl J Med 1991;324:1677-1684.
-
(1991)
N Engl J Med
, vol.324
, pp. 1677-1684
-
-
Redfield, R.R.1
Birx, D.L.2
Ketter, N.3
Tramont, E.4
Polonis, V.5
-
4
-
-
0028024901
-
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1
-
Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, et al.: Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. JAMA 1994;272:475-480.
-
(1994)
JAMA
, vol.272
, pp. 475-480
-
-
Belshe, R.B.1
Graham, B.S.2
Keefer, M.C.3
Gorse, G.J.4
Wright, P.5
Dolin, R.6
Matthews, T.7
-
5
-
-
0027178289
-
Induction of HIV-1 neutralizing and syncytium-inhibiting antibodies in uninfected recipients of HIV-IIIB rgp120 subunit vaccine
-
Schwartz DH, Gorse G, Clements ML, Belshe R, Izu A, Duliege A-M, Berman P, Twaddell T, Stablein D, Sposto R, Siliciano R, and Matthews T: Induction of HIV-1 neutralizing and syncytium-inhibiting antibodies in uninfected recipients of HIV-IIIB rgp120 subunit vaccine. Lancet 1993;342:69-73.
-
(1993)
Lancet
, vol.342
, pp. 69-73
-
-
Schwartz, D.H.1
Gorse, G.2
Clements, M.L.3
Belshe, R.4
Izu, A.5
Duliege, A.-M.6
Berman, P.7
Twaddell, T.8
Stablein, D.9
Sposto, R.10
Siliciano, R.11
Matthews, T.12
-
6
-
-
0030586434
-
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: Recombinant glycoprotein (rgp) gp120
-
Graham BS, Keefer MC, McElrath J, Gorse GJ, Schwartz DH, Weinhold K, Matthews TJ, Esterlitz JR, Sinangil F, and Fast PE: Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: Recombinant glycoprotein (rgp) gp120. Ann Intern Med 1996;125:270-279.
-
(1996)
Ann Intern Med
, vol.125
, pp. 270-279
-
-
Graham, B.S.1
Keefer, M.C.2
McElrath, J.3
Gorse, G.J.4
Schwartz, D.H.5
Weinhold, K.6
Matthews, T.J.7
Esterlitz, J.R.8
Sinangil, F.9
Fast, P.E.10
-
7
-
-
0027988552
-
SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers
-
SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers. J Infect Dis 1994;170: 1288-1291.
-
(1994)
J Infect Dis
, vol.170
, pp. 1288-1291
-
-
Kahn, J.O.1
Sinangil, F.2
Baenziger, J.3
Murcar, N.4
Wynne, D.5
Coleman, R.L.6
Steimer, K.S.7
Dekker, C.L.8
Chernoff, D.9
-
8
-
-
0023028190
-
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
-
Maddon P, Dalgleish AG, McDougal JS, Clapham PN, Weiss RA, and Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47: 333-348.
-
(1986)
Cell
, vol.47
, pp. 333-348
-
-
Maddon, P.1
Dalgleish, A.G.2
McDougal, J.S.3
Clapham, P.N.4
Weiss, R.A.5
Axel, R.6
-
9
-
-
0023491395
-
HIV infection of primate lymphocytes and conservation of the CD4 receptor
-
McClure MD, Sattentau QJ, Beverley PC, Hearn JP, Fitzgerald AK, Zuckemian AJ, and Weiss RA: HIV infection of primate lymphocytes and conservation of the CD4 receptor. Nature (London) 1987;330:487-489.
-
(1987)
Nature (London)
, vol.330
, pp. 487-489
-
-
McClure, M.D.1
Sattentau, Q.J.2
Beverley, P.C.3
Hearn, J.P.4
Fitzgerald, A.K.5
Zuckemian, A.J.6
Weiss, R.A.7
-
10
-
-
0030002637
-
HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
-
Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
-
(1996)
Science
, vol.272
, pp. 872-877
-
-
Feng, Y.1
Broder, C.C.2
Kennedy, P.E.3
Berger, E.A.4
-
11
-
-
15844419153
-
Identification of a major coreceptor for primary isolates of HIV-1
-
Deng HK, Liu R, Ellmeier W, Choe S, et al.: Identification of a major coreceptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
-
(1996)
Nature (London)
, vol.381
, pp. 661-666
-
-
Deng, H.K.1
Liu, R.2
Ellmeier, W.3
Choe, S.4
-
12
-
-
15844389650
-
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
-
Dragic T, Litwin V, Allaway GP, et al.: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673.
-
(1996)
Nature (London)
, vol.381
, pp. 667-673
-
-
Dragic, T.1
Litwin, V.2
Allaway, G.P.3
-
13
-
-
0023217711
-
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1
-
Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Haseltine W, and Sodroski J: Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 1987;237:1351-1355.
-
(1987)
Science
, vol.237
, pp. 1351-1355
-
-
Kowalski, M.1
Potz, J.2
Basiripour, L.3
Dorfman, T.4
Goh, W.C.5
Terwilliger, E.6
Dayton, A.7
Rosen, C.8
Haseltine, W.9
Sodroski, J.10
-
14
-
-
0025866185
-
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding
-
Sattentau QJ and Moore JP: Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991;174:407-415.
-
(1991)
J Exp Med
, vol.174
, pp. 407-415
-
-
Sattentau, Q.J.1
Moore, J.P.2
-
15
-
-
0030970693
-
Core structure of gp41 from the HIV envelope glycoprotein
-
Chan DC, Fass D, Berger JM, and Kim PS: Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997;89:263-273.
-
(1997)
Cell
, vol.89
, pp. 263-273
-
-
Chan, D.C.1
Fass, D.2
Berger, J.M.3
Kim, P.S.4
-
16
-
-
0029973261
-
CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1
-
Berkower I, Mostowski H, Bull TE, and Murphy D: CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1. J Infect Dis 1996;173:863-869.
-
(1996)
J Infect Dis
, vol.173
, pp. 863-869
-
-
Berkower, I.1
Mostowski, H.2
Bull, T.E.3
Murphy, D.4
-
17
-
-
0026044947
-
Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120
-
Steimer KS, Scandella CJ, Skiles PV, and Haigwood NL: Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 1991;254:105-108.
-
(1991)
Science
, vol.254
, pp. 105-108
-
-
Steimer, K.S.1
Scandella, C.J.2
Skiles, P.V.3
Haigwood, N.L.4
-
18
-
-
0025775863
-
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans
-
Kang C-Y, Nara P, Chamat S, et al.: Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci USA 1991;88:6171-6175.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 6171-6175
-
-
Kang, C.-Y.1
Nara, P.2
Chamat, S.3
-
19
-
-
0025932084
-
A predominant group specific neutralizing epitope of HIV-1 maps to residues 342-511 of the envelope glycoprotein gp120
-
Berkower I, Murphy D, Smith CC, and Smith GE: A predominant group specific neutralizing epitope of HIV-1 maps to residues 342-511 of the envelope glycoprotein gp120. J Virol 1991;65: 5983-5990.
-
(1991)
J Virol
, vol.65
, pp. 5983-5990
-
-
Berkower, I.1
Murphy, D.2
Smith, C.C.3
Smith, G.E.4
-
20
-
-
0026085170
-
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody
-
Thali M, Olshevsky U, Furman C, Gabuzda D, Posner M, and Sodroski J: Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J Virol 1991;65: 6188-6193.
-
(1991)
J Virol
, vol.65
, pp. 6188-6193
-
-
Thali, M.1
Olshevsky, U.2
Furman, C.3
Gabuzda, D.4
Posner, M.5
Sodroski, J.6
-
21
-
-
0025821179
-
A human monoclonal antibody against the CD4-binding site of HIV-1 gp120 exhibits potent, broadly neutralizing activity
-
Tilley SA, Honnen WJ, Racho ME, Hilgartner M, and Pinter A: A human monoclonal antibody against the CD4-binding site of HIV-1 gp120 exhibits potent, broadly neutralizing activity. Inst Pasteur Res Virol 1991;142:247-259.
-
(1991)
Inst Pasteur Res Virol
, vol.142
, pp. 247-259
-
-
Tilley, S.A.1
Honnen, W.J.2
Racho, M.E.3
Hilgartner, M.4
Pinter, A.5
-
22
-
-
0026567492
-
Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region
-
Pollard ST, Rosa MD, Rosa JJ, and Wiley DC: Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J 1992;11:585-591.
-
(1992)
EMBO J
, vol.11
, pp. 585-591
-
-
Pollard, S.T.1
Rosa, M.D.2
Rosa, J.J.3
Wiley, D.C.4
-
23
-
-
0027395037
-
Reconstitution of the subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: Identification of a human CD4. enhancer
-
Blum MD, Wong GT, Higgins KM, Sunshine MJ, and Lacy E: Reconstitution of the subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: Identification of a human CD4. enhancer. J Exp Med 1993;177:1343-1358.
-
(1993)
J Exp Med
, vol.177
, pp. 1343-1358
-
-
Blum, M.D.1
Wong, G.T.2
Higgins, K.M.3
Sunshine, M.J.4
Lacy, E.5
-
24
-
-
0042488352
-
Ir genes: Antigen-specific genetic regulation of the immune response
-
(M. Sela, ed.), Academic Press, New York
-
Berzofsky JA: Ir genes: Antigen-specific genetic regulation of the immune response. In: The Antigens (M. Sela, ed.), Vol. 7. Academic Press, New York, 1987, pp. 1-146.
-
(1987)
The Antigens
, vol.7
, pp. 1-146
-
-
Berzofsky, J.A.1
-
26
-
-
0029433427
-
Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes; advances in 1994-95
-
Berzofsky JA and Berkower IJ: Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes; advances in 1994-95. AIDS 1995;9(Suppl. A):S143-S157.
-
(1995)
AIDS
, vol.9
, Issue.SUPPL. A
-
-
Berzofsky, J.A.1
Berkower, I.J.2
-
27
-
-
0002972414
-
Use of baculovirus recombinants as a general method for the production of subunit vaccines
-
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
-
Cochran MA, Ericson BL, Knell JD, and Smith GE: Use of baculovirus recombinants as a general method for the production of subunit vaccines. In: Vaccines 87: Modern Approaches to New Vaccines: Prevention of AIDS and Other Viral, Bacterial, and Parasitic Diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1987, pp. 384-388.
-
(1987)
Vaccines 87: Modern Approaches to New Vaccines: Prevention of AIDS and Other Viral, Bacterial, and Parasitic Diseases
, pp. 384-388
-
-
Cochran, M.A.1
Ericson, B.L.2
Knell, J.D.3
Smith, G.E.4
-
28
-
-
0027814829
-
Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development
-
Scandella CJ, Kilpatrick J, Lidster W, Parker C, Moore JP, Moore GK, Mann KA, Brown P, Coates S, Chapman B, Masiarz FR, Steimer KS, and Haigwood NL: Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development. Aids Res Hum Retroviruses 1993;9:1233-1244.
-
(1993)
Aids Res Hum Retroviruses
, vol.9
, pp. 1233-1244
-
-
Scandella, C.J.1
Kilpatrick, J.2
Lidster, W.3
Parker, C.4
Moore, J.P.5
Moore, G.K.6
Mann, K.A.7
Brown, P.8
Coates, S.9
Chapman, B.10
Masiarz, F.R.11
Steimer, K.S.12
Haigwood, N.L.13
-
29
-
-
0027250724
-
Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1
-
Berkower I and Murphy D: Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1. Biochem Biophys Res Commun 1993;191:1055-1065.
-
(1993)
Biochem Biophys Res Commun
, vol.191
, pp. 1055-1065
-
-
Berkower, I.1
Murphy, D.2
-
30
-
-
0003518435
-
-
Los Alamos National Laboratory, Los Alamos, New Mexico
-
Myers G, Rabson AB, Berzofsky JA, Smith TF, and Wong-Staal F: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1992.
-
(1992)
Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences
-
-
Myers, G.1
Rabson, A.B.2
Berzofsky, J.A.3
Smith, T.F.4
Wong-Staal, F.5
-
31
-
-
0025292252
-
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
-
Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, and Gregory TJ: Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990;265: 10373-10382.
-
(1990)
J Biol Chem
, vol.265
, pp. 10373-10382
-
-
Leonard, C.K.1
Spellman, M.W.2
Riddle, L.3
Harris, R.J.4
Thomas, J.N.5
Gregory, T.J.6
-
32
-
-
0024267990
-
Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen: Identification of class II loci of the H-2 as immune response genes
-
Miyazawa M, Nishio J, and Chesebro B: Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen: Identification of class II loci of the H-2 as immune response genes. J Exp Med 1988;168:1587-1605.
-
(1988)
J Exp Med
, vol.168
, pp. 1587-1605
-
-
Miyazawa, M.1
Nishio, J.2
Chesebro, B.3
-
33
-
-
0001384870
-
Genetic control of murine viral leukemogenesis
-
Lilly F and Pincus T: Genetic control of murine viral leukemogenesis. Adv Cancer Res 1973;17:231-277.
-
(1973)
Adv Cancer Res
, vol.17
, pp. 231-277
-
-
Lilly, F.1
Pincus, T.2
-
34
-
-
0025214163
-
Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection
-
Chesebro B, Miyazawa M, and Britt WJ: Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu Rev Immunol 1990;8:477-499.
-
(1990)
Annu Rev Immunol
, vol.8
, pp. 477-499
-
-
Chesebro, B.1
Miyazawa, M.2
Britt, W.J.3
-
35
-
-
0017688395
-
Resistance genes to murine leukemia in the I immune response gene region of the H-2 complex
-
Lonai P and Haran-Ghera N: Resistance genes to murine leukemia in the I immune response gene region of the H-2 complex. J Exp Med 1977;146:1164-1168.
-
(1977)
J Exp Med
, vol.146
, pp. 1164-1168
-
-
Lonai, P.1
Haran-Ghera, N.2
-
36
-
-
0016269959
-
Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice
-
Muhlbock O and Dux A: Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice. J Natl Cancer Inst 1974;53:993-996.
-
(1974)
J Natl Cancer Inst
, vol.53
, pp. 993-996
-
-
Muhlbock, O.1
Dux, A.2
-
37
-
-
1842364256
-
Helper T cell antigenic site identification in the AIDS virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide
-
Cease KB, Margalit H, Cornette JL, Putney SD, Robey WG, Ouyang C, Streicher HZ, et al.: Helper T cell antigenic site identification in the AIDS virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci USA 1987;84:4249-4253.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 4249-4253
-
-
Cease, K.B.1
Margalit, H.2
Cornette, J.L.3
Putney, S.D.4
Robey, W.G.5
Ouyang, C.6
Streicher, H.Z.7
-
38
-
-
0024445880
-
T cell multideterminant regions in the human immunodeficiency virus envelope: Toward overcoming the problem of major histocompatibility complex restriction
-
Hale PM, Cease KB, Houghten RA, Ouyang C, Putney S, Javaherian K, Margalit H, Comette JL, Spouge JL, DeLisi C, and Berzofsky JA: T cell multideterminant regions in the human immunodeficiency virus envelope: Toward overcoming the problem of major histocompatibility complex restriction. Int Immunol 1989;1:409-415.
-
(1989)
Int Immunol
, vol.1
, pp. 409-415
-
-
Hale, P.M.1
Cease, K.B.2
Houghten, R.A.3
Ouyang, C.4
Putney, S.5
Javaherian, K.6
Margalit, H.7
Comette, J.L.8
Spouge, J.L.9
DeLisi, C.10
Berzofsky, J.A.11
-
39
-
-
0029975955
-
Candidate HIV type 1 multideterminant cluster peptide-p18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells and neutralizing antibody, all using the same adjuvant immunization
-
Ahlers JD, Dunlop N, Pendleton CD, Newman M, Nara PL, and Berzofsky JA: Candidate HIV type 1 multideterminant cluster peptide-p18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells and neutralizing antibody, all using the same adjuvant immunization. AIDS Res Hum Retroviruses 1996;12:259-272.
-
(1996)
AIDS Res Hum Retroviruses
, vol.12
, pp. 259-272
-
-
Ahlers, J.D.1
Dunlop, N.2
Pendleton, C.D.3
Newman, M.4
Nara, P.L.5
Berzofsky, J.A.6
-
40
-
-
0004040193
-
-
Section II. Los Alamos National Laboratory, Los Alamos, New Mexico
-
Korber BTM, Brander C, Walker BD, Koup R, Moore JP, Haynes BF, and Myers G: HIV Molecular Immunology Database 1995, Section II. Los Alamos National Laboratory, Los Alamos, New Mexico, 1995.
-
(1995)
HIV Molecular Immunology Database 1995
-
-
Korber, B.T.M.1
Brander, C.2
Walker, B.D.3
Koup, R.4
Moore, J.P.5
Haynes, B.F.6
Myers, G.7
-
41
-
-
23444461024
-
How B and T cells talk to each other
-
Clark EA and Ledbetter JA: How B and T cells talk to each other. Nature (London) 1994;367:425-428.
-
(1994)
Nature (London)
, vol.367
, pp. 425-428
-
-
Clark, E.A.1
Ledbetter, J.A.2
-
42
-
-
0026019644
-
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans
-
Dolin R, Graham BS, Greenberg SB, et al.: The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. Ann Intern Med 1991;114:119-127.
-
(1991)
Ann Intern Med
, vol.114
, pp. 119-127
-
-
Dolin, R.1
Graham, B.S.2
Greenberg, S.B.3
-
43
-
-
0028670689
-
Studies of high doses of human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans
-
Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Monterfiori DC, et al.: Studies of high doses of human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. AIDS Res 1994;10:1713-1723.
-
(1994)
AIDS Res
, vol.10
, pp. 1713-1723
-
-
Keefer, M.C.1
Graham, B.S.2
Belshe, R.B.3
Schwartz, D.4
Corey, L.5
Bolognesi, D.P.6
Stablein, D.M.7
Monterfiori, D.C.8
-
44
-
-
0024786954
-
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients: Independence of CD4 cell numbers and clinical staging
-
Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, and Shearer GM: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients: Independence of CD4 cell numbers and clinical staging. J Clin Invest 1989;84:1892-1899.
-
(1989)
J Clin Invest
, vol.84
, pp. 1892-1899
-
-
Clerici, M.1
Stocks, N.I.2
Zajac, R.A.3
Boswell, R.N.4
Lucey, D.R.5
Via, C.S.6
Shearer, G.M.7
-
45
-
-
0028971410
-
Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein
-
Gorse GJ, Patel GB, Newman FK, Mandava M, and Belshe RB: Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. Vaccine 1995;13:1170-1179.
-
(1995)
Vaccine
, vol.13
, pp. 1170-1179
-
-
Gorse, G.J.1
Patel, G.B.2
Newman, F.K.3
Mandava, M.4
Belshe, R.B.5
-
46
-
-
0028213153
-
Comparison of the immune response to recombinant gp120 in humans and chimpanzees
-
Berman PW, Eastman DJ, Wilkes DM, Nakamura GR, Gregory TJ, Schwartz D, Gorse G, Belshe R, Clements ML, and Byrn RA: Comparison of the immune response to recombinant gp120 in humans and chimpanzees. AIDS 1994;8:591-601.
-
(1994)
AIDS
, vol.8
, pp. 591-601
-
-
Berman, P.W.1
Eastman, D.J.2
Wilkes, D.M.3
Nakamura, G.R.4
Gregory, T.J.5
Schwartz, D.6
Gorse, G.7
Belshe, R.8
Clements, M.L.9
Byrn, R.A.10
-
47
-
-
0028892847
-
Resistance of chimpanzees immunized with recombinant gp120 SF2 to challenge by HIV-1 SF2
-
El-Amad Z, Murthy KK, Higgins K, Cobb EK, Haigwood NL, Levy JA, and Steimer KS: Resistance of chimpanzees immunized with recombinant gp120 SF2 to challenge by HIV-1 SF2. AIDS 1995;9:1313-1322.
-
(1995)
AIDS
, vol.9
, pp. 1313-1322
-
-
El-Amad, Z.1
Murthy, K.K.2
Higgins, K.3
Cobb, E.K.4
Haigwood, N.L.5
Levy, J.A.6
Steimer, K.S.7
-
48
-
-
84959850495
-
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial
-
Kahn JO, Steimer KS, Baenziger J, Duliege A-M, Feinberg M, Elbeik T, Chesney M, Murcar N, Chernoff D, and Sinangil F: Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial. J Infect Dis 1995;171:1343-1347.
-
(1995)
J Infect Dis
, vol.171
, pp. 1343-1347
-
-
Kahn, J.O.1
Steimer, K.S.2
Baenziger, J.3
Duliege, A.-M.4
Feinberg, M.5
Elbeik, T.6
Chesney, M.7
Murcar, N.8
Chernoff, D.9
Sinangil, F.10
-
49
-
-
0023256269
-
Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site
-
Milich DR, McLachlan A, Thornton GB, and Hughes JL: Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature (London) 1987;329:547-549.
-
(1987)
Nature (London)
, vol.329
, pp. 547-549
-
-
Milich, D.R.1
McLachlan, A.2
Thornton, G.B.3
Hughes, J.L.4
-
50
-
-
0030974498
-
Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity
-
Cole KS, Rowles JL, Jagerski BA, Murphey-Corb M, Unangst T, Clements JE, Robinson J, Wyand MS, Desrosiers RC, and Montelaro RC: Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 1997;71:5069-5079.
-
(1997)
J Virol
, vol.71
, pp. 5069-5079
-
-
Cole, K.S.1
Rowles, J.L.2
Jagerski, B.A.3
Murphey-Corb, M.4
Unangst, T.5
Clements, J.E.6
Robinson, J.7
Wyand, M.S.8
Desrosiers, R.C.9
Montelaro, R.C.10
-
51
-
-
0030975067
-
Antibodies with specificity to native gp120 and neutralization activity against primary HIV-1 isolates elicited by immunization with oligomeric gp160
-
VanCott TC, Mascola JR, Kaminski RW, Kalyanaraman V, Hallberg PL, Burnett PR, Ulrich JT, Rechtman DJ, and Birx DL: Antibodies with specificity to native gp120 and neutralization activity against primary HIV-1 isolates elicited by immunization with oligomeric gp160. J Virol 1997;71:4319-4330.
-
(1997)
J Virol
, vol.71
, pp. 4319-4330
-
-
Vancott, T.C.1
Mascola, J.R.2
Kaminski, R.W.3
Kalyanaraman, V.4
Hallberg, P.L.5
Burnett, P.R.6
Ulrich, J.T.7
Rechtman, D.J.8
Birx, D.L.9
-
52
-
-
0005848581
-
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein
-
Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD, and Matthews TJ: Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 1989;86:6768-6772.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 6768-6772
-
-
Javaherian, K.1
Langlois, A.J.2
McDanal, C.3
Ross, K.L.4
Eckler, L.I.5
Jellis, C.L.6
Profy, A.T.7
Rusche, J.R.8
Bolognesi, D.P.9
Putney, S.D.10
Matthews, T.J.11
-
53
-
-
0031048822
-
The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands
-
Madrenas J, Chau LA, Smith J, Bluestone JA, and Germain RN: The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J Exp Med 1997;185:219-229.
-
(1997)
J Exp Med
, vol.185
, pp. 219-229
-
-
Madrenas, J.1
Chau, L.A.2
Smith, J.3
Bluestone, J.A.4
Germain, R.N.5
-
54
-
-
0028240826
-
Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients
-
Wang Z-Q, Orlikowsky T, Dudhane A, et al.: Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients. Eur J Immunol 1994;24:1553-1557.
-
(1994)
Eur J Immunol
, vol.24
, pp. 1553-1557
-
-
Wang, Z.-Q.1
Orlikowsky, T.2
Dudhane, A.3
|